NO326227B1 - Nye stereoselektive fremgangsmater for fremstilling av gabapentinanaloger - Google Patents
Nye stereoselektive fremgangsmater for fremstilling av gabapentinanaloger Download PDFInfo
- Publication number
- NO326227B1 NO326227B1 NO20001404A NO20001404A NO326227B1 NO 326227 B1 NO326227 B1 NO 326227B1 NO 20001404 A NO20001404 A NO 20001404A NO 20001404 A NO20001404 A NO 20001404A NO 326227 B1 NO326227 B1 NO 326227B1
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- prepare
- solvent
- dissolving
- compound
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical class OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract description 10
- 238000000034 method Methods 0.000 title abstract description 8
- 238000002360 preparation method Methods 0.000 title abstract description 3
- 230000000707 stereoselective effect Effects 0.000 title abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 48
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 32
- 239000002904 solvent Substances 0.000 claims description 22
- 150000002148 esters Chemical class 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- 150000003951 lactams Chemical class 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 9
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 8
- 239000012312 sodium hydride Substances 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 claims description 6
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 claims description 4
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- MQWCXKGKQLNYQG-UHFFFAOYSA-N methyl cyclohexan-4-ol Natural products CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 claims description 2
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 3
- MSANHHHQJYQEOK-UHFFFAOYSA-N 3,5-dimethylcyclohexan-1-one Chemical compound CC1CC(C)CC(=O)C1 MSANHHHQJYQEOK-UHFFFAOYSA-N 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 239000007787 solid Substances 0.000 description 9
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- -1 triphenylphosphonium halide Chemical class 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- 239000007868 Raney catalyst Substances 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 238000003818 flash chromatography Methods 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-PTQBSOBMSA-N cyclohexanone Chemical class O=[13C]1CCCCC1 JHIVVAPYMSGYDF-PTQBSOBMSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MSANHHHQJYQEOK-KNVOCYPGSA-N (3r,5s)-3,5-dimethylcyclohexan-1-one Chemical compound C[C@H]1C[C@@H](C)CC(=O)C1 MSANHHHQJYQEOK-KNVOCYPGSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 125000005079 alkoxycarbonylmethyl group Chemical group 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexyloxide Natural products O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960002870 gabapentin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5920497P | 1997-09-18 | 1997-09-18 | |
PCT/US1998/016652 WO1999014184A1 (en) | 1997-09-18 | 1998-08-11 | Novel stereoselective processes for the preparation of gabapentin analogues |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20001404D0 NO20001404D0 (no) | 2000-03-17 |
NO20001404L NO20001404L (no) | 2000-03-17 |
NO326227B1 true NO326227B1 (no) | 2008-10-20 |
Family
ID=22021467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001404A NO326227B1 (no) | 1997-09-18 | 2000-03-17 | Nye stereoselektive fremgangsmater for fremstilling av gabapentinanaloger |
Country Status (20)
Country | Link |
---|---|
US (1) | US6465689B1 (de) |
EP (1) | EP1015415B1 (de) |
JP (1) | JP3878809B2 (de) |
KR (1) | KR100563894B1 (de) |
AT (1) | ATE239695T1 (de) |
AU (1) | AU752444B2 (de) |
BR (1) | BR9812351A (de) |
CA (1) | CA2295993C (de) |
DE (1) | DE69814420T2 (de) |
DK (1) | DK1015415T3 (de) |
ES (1) | ES2197493T3 (de) |
HU (1) | HUP0004582A3 (de) |
IL (2) | IL133782A0 (de) |
IS (1) | IS2198B (de) |
NO (1) | NO326227B1 (de) |
NZ (1) | NZ502786A (de) |
PL (1) | PL192180B1 (de) |
PT (1) | PT1015415E (de) |
WO (1) | WO1999014184A1 (de) |
ZA (1) | ZA988508B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10203122A1 (de) * | 2002-01-25 | 2003-07-31 | Gruenenthal Gmbh | Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren |
EP1615875A2 (de) | 2003-04-21 | 2006-01-18 | Matrix Laboratories Limited | Verfahren zur herstellung von gabapentin form-ii |
US20050187295A1 (en) * | 2004-02-19 | 2005-08-25 | Surendra Kalyan | Processes for the preparation of gabapentin |
US7632864B2 (en) | 2004-03-17 | 2009-12-15 | Hikal Ltd. | Gabapentin analogues and process thereof |
WO2005087709A1 (en) | 2004-03-17 | 2005-09-22 | Hikal Limited | 4-t-butylgabapentin and its synthesis |
US7442834B2 (en) | 2006-06-12 | 2008-10-28 | Zhejiang Chiral Medicine Chemicals Co., Ltd. | Process suitable for industrial scale production of gabapentin |
WO2013190357A1 (en) * | 2012-06-18 | 2013-12-27 | Hikal Limited | A process for the preparation of gabapentin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3928182A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von gabapentin |
KR19990082349A (ko) | 1996-02-07 | 1999-11-25 | 로즈 암스트롱 | 제약학적 제제로서 신규한 시클릭 아미노산 |
JP2000506862A (ja) * | 1996-03-14 | 2000-06-06 | ワーナー―ランバート・コンパニー | 医薬としての新規な架橋環状アミノ酸 |
-
1998
- 1998-08-11 JP JP2000511737A patent/JP3878809B2/ja not_active Expired - Fee Related
- 1998-08-11 ES ES98939340T patent/ES2197493T3/es not_active Expired - Lifetime
- 1998-08-11 IL IL13378298A patent/IL133782A0/xx active IP Right Grant
- 1998-08-11 WO PCT/US1998/016652 patent/WO1999014184A1/en active IP Right Grant
- 1998-08-11 EP EP98939340A patent/EP1015415B1/de not_active Expired - Lifetime
- 1998-08-11 DK DK98939340T patent/DK1015415T3/da active
- 1998-08-11 CA CA002295993A patent/CA2295993C/en not_active Expired - Fee Related
- 1998-08-11 NZ NZ502786A patent/NZ502786A/en unknown
- 1998-08-11 US US09/445,633 patent/US6465689B1/en not_active Expired - Fee Related
- 1998-08-11 DE DE69814420T patent/DE69814420T2/de not_active Expired - Fee Related
- 1998-08-11 HU HU0004582A patent/HUP0004582A3/hu unknown
- 1998-08-11 AU AU87791/98A patent/AU752444B2/en not_active Ceased
- 1998-08-11 AT AT98939340T patent/ATE239695T1/de not_active IP Right Cessation
- 1998-08-11 PT PT98939340T patent/PT1015415E/pt unknown
- 1998-08-11 PL PL339296A patent/PL192180B1/pl not_active IP Right Cessation
- 1998-08-11 BR BR9812351-3A patent/BR9812351A/pt active Search and Examination
- 1998-08-11 KR KR1020007002825A patent/KR100563894B1/ko not_active IP Right Cessation
- 1998-09-17 ZA ZA988508A patent/ZA988508B/xx unknown
-
1999
- 1999-12-29 IL IL133782A patent/IL133782A/en not_active IP Right Cessation
-
2000
- 2000-01-21 IS IS5355A patent/IS2198B/is unknown
- 2000-03-17 NO NO20001404A patent/NO326227B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20001404D0 (no) | 2000-03-17 |
KR20010024079A (ko) | 2001-03-26 |
HUP0004582A2 (hu) | 2001-05-28 |
CA2295993C (en) | 2004-05-04 |
BR9812351A (pt) | 2000-09-19 |
IL133782A0 (en) | 2001-04-30 |
ES2197493T3 (es) | 2004-01-01 |
ATE239695T1 (de) | 2003-05-15 |
DE69814420T2 (de) | 2003-11-27 |
KR100563894B1 (ko) | 2006-03-24 |
AU8779198A (en) | 1999-04-05 |
DE69814420D1 (de) | 2003-06-12 |
NZ502786A (en) | 2002-05-31 |
IS2198B (is) | 2007-02-15 |
NO20001404L (no) | 2000-03-17 |
US6465689B1 (en) | 2002-10-15 |
JP2001516738A (ja) | 2001-10-02 |
HUP0004582A3 (en) | 2002-01-28 |
IL133782A (en) | 2006-12-31 |
JP3878809B2 (ja) | 2007-02-07 |
DK1015415T3 (da) | 2003-07-21 |
WO1999014184A1 (en) | 1999-03-25 |
PL192180B1 (pl) | 2006-09-29 |
ZA988508B (en) | 1999-03-30 |
AU752444B2 (en) | 2002-09-19 |
IS5355A (is) | 2000-05-22 |
EP1015415B1 (de) | 2003-05-07 |
EP1015415A1 (de) | 2000-07-05 |
PT1015415E (pt) | 2003-09-30 |
CA2295993A1 (en) | 1999-03-25 |
PL339296A1 (en) | 2000-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2397164C2 (ru) | ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3f,12b-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]-ОКСЕПИНО[4,5-c]ПИРРОЛА | |
MX2007012606A (es) | Proceso para elaborar (s)-pregabalina. | |
PL199794B1 (pl) | Związki pośrednie do wytwarzania pochodnych cyklicznych aminokwasów | |
EP2403823B1 (de) | Verfahren zur herstellung von cinacalcet und salzen davon und zwischenprodukte zur verwendung in dem verfahren | |
US5130455A (en) | Process for the production of 1-(aminomethyl) cyclohexane acetic acid | |
HU226475B1 (en) | Process for producing (1r,4s)- and (1s,4r)-1-amino-4-hydroxymethyl-2-cyclopentene and the new intermediates | |
NO326227B1 (no) | Nye stereoselektive fremgangsmater for fremstilling av gabapentinanaloger | |
EP2061318B1 (de) | Verfarhen für die synthese von (+)- und (-)-1-(3,4-dichlorphenyl)-3-azabicyclo[3.1.0]hexan | |
US5136091A (en) | Process for the production of 1-(aminomethyl) cyclohexane acetic acid | |
EP1347960A1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
US5149870A (en) | Process for the production of 1-(aminomethyl)cyclohexane acetic acid | |
MXPA00000063A (en) | Novel stereoselective processes for the preparation of gabapentin analogues | |
EA003555B1 (ru) | Способ получения 1-(аминометил)циклогексилуксусной кислоты | |
JP3221636B2 (ja) | 3−フェニルスルホニルアミノ−ビシクロ[2,2,1]ヘプタン−2−カルボン酸アルキルエステルの製造方法 | |
JPH10158239A (ja) | 4−ヒドロキシ−2−ピロリジノンの製造方法ならびに精製方法 | |
US20010053862A1 (en) | Process for preparing arylpiperidine carbinol intermediates and derivatives | |
JPH07242614A (ja) | 光学活性なオキシム誘導体およびその製造方法 | |
JPH0959265A (ja) | 光学活性オキサゾリジノン、その製造方法、製造の中間体および不斉補助基としての利用 | |
AU2001226773A1 (en) | Process for preparing (plus or minus) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |